Synthesis and structure–activity relationships of aminoalkylazetidines as ORL1 receptor ligands
Wen‐Lian Wu, Duane A. Burnett(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mary Ann Caplen, Martin S. Domalski, Hongtao Zhang(Chinese Academy of Sciences), Ahmad Fawzi
Cited by 17
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
Magnetically Propelled Fish‐Like Nanoswimmers
|Small|2016|271